Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes
This matters in several specific research contexts
Introducing, Feel Pro Metabolic (from 39.96, Wearefeel.com), the next-gen supplement designed to regulate your hunger urges and support your bodys energy processes gently and sustainably
But the practice of providing compounded GLP-1s is not sustainable, even if Hims and others try to fight it by creating different enough drugs under the compounding process
Focus on leafy greens, colorful vegetables, and lean proteins, which provide nutrients without the risk of an acute drug-herb interaction